1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by MicroRNA Revenue
1.4 Market by Type
1.4.1 Global MicroRNA Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PCR-based Assay
1.4.3 miRNA Arrays
1.4.4 Next Generation Sequencing (NGS)
1.4.5 Immunoassay
1.5 Market by Application
1.5.1 Global MicroRNA Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Academic and Research Institutes
1.5.4 Biopharmaceutical Companies
1.5.5 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global MicroRNA Market Perspective (2015-2026)
2.2 Global MicroRNA Growth Trends by Regions
2.2.1 MicroRNA Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 MicroRNA Historic Market Share by Regions (2015-2020)
2.2.3 MicroRNA Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 MicroRNA Market Growth Strategy
2.3.6 Primary Interviews with Key MicroRNA Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top MicroRNA Players by Market Size
3.1.1 Global Top MicroRNA Players by Revenue (2015-2020)
3.1.2 Global MicroRNA Revenue Market Share by Players (2015-2020)
3.1.3 Global MicroRNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global MicroRNA Market Concentration Ratio
3.2.1 Global MicroRNA Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by MicroRNA Revenue in 2019
3.3 MicroRNA Key Players Head office and Area Served
3.4 Key Players MicroRNA Product Solution and Service
3.5 Date of Enter into MicroRNA Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global MicroRNA Historic Market Size by Type (2015-2020)
4.2 Global MicroRNA Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global MicroRNA Market Size by Application (2015-2020)
5.2 Global MicroRNA Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America MicroRNA Market Size (2015-2020)
6.2 MicroRNA Key Players in North America (2019-2020)
6.3 North America MicroRNA Market Size by Type (2015-2020)
6.4 North America MicroRNA Market Size by Application (2015-2020)
7 Europe
7.1 Europe MicroRNA Market Size (2015-2020)
7.2 MicroRNA Key Players in Europe (2019-2020)
7.3 Europe MicroRNA Market Size by Type (2015-2020)
7.4 Europe MicroRNA Market Size by Application (2015-2020)
8 China
8.1 China MicroRNA Market Size (2015-2020)
8.2 MicroRNA Key Players in China (2019-2020)
8.3 China MicroRNA Market Size by Type (2015-2020)
8.4 China MicroRNA Market Size by Application (2015-2020)
9 Japan
9.1 Japan MicroRNA Market Size (2015-2020)
9.2 MicroRNA Key Players in Japan (2019-2020)
9.3 Japan MicroRNA Market Size by Type (2015-2020)
9.4 Japan MicroRNA Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia MicroRNA Market Size (2015-2020)
10.2 MicroRNA Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia MicroRNA Market Size by Type (2015-2020)
10.4 Southeast Asia MicroRNA Market Size by Application (2015-2020)
11 India
11.1 India MicroRNA Market Size (2015-2020)
11.2 MicroRNA Key Players in India (2019-2020)
11.3 India MicroRNA Market Size by Type (2015-2020)
11.4 India MicroRNA Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America MicroRNA Market Size (2015-2020)
12.2 MicroRNA Key Players in Central & South America (2019-2020)
12.3 Central & South America MicroRNA Market Size by Type (2015-2020)
12.4 Central & South America MicroRNA Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview
13.1.3 Illumina MicroRNA Introduction
13.1.4 Illumina Revenue in MicroRNA Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche MicroRNA Introduction
13.2.4 Roche Revenue in MicroRNA Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Agilent
13.3.1 Agilent Company Details
13.3.2 Agilent Business Overview
13.3.3 Agilent MicroRNA Introduction
13.3.4 Agilent Revenue in MicroRNA Business (2015-2020)
13.3.5 Agilent Recent Development
13.4 Bio-Rad
13.4.1 Bio-Rad Company Details
13.4.2 Bio-Rad Business Overview
13.4.3 Bio-Rad MicroRNA Introduction
13.4.4 Bio-Rad Revenue in MicroRNA Business (2015-2020)
13.4.5 Bio-Rad Recent Development
13.5 Sigma Aldrich
13.5.1 Sigma Aldrich Company Details
13.5.2 Sigma Aldrich Business Overview
13.5.3 Sigma Aldrich MicroRNA Introduction
13.5.4 Sigma Aldrich Revenue in MicroRNA Business (2015-2020)
13.5.5 Sigma Aldrich Recent Development
13.6 Qiagen
13.6.1 Qiagen Company Details
13.6.2 Qiagen Business Overview
13.6.3 Qiagen MicroRNA Introduction
13.6.4 Qiagen Revenue in MicroRNA Business (2015-2020)
13.6.5 Qiagen Recent Development
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Details
13.7.2 Thermo Fisher Scientific Business Overview
13.7.3 Thermo Fisher Scientific MicroRNA Introduction
13.7.4 Thermo Fisher Scientific Revenue in MicroRNA Business (2015-2020)
13.7.5 Thermo Fisher Scientific Recent Development
13.8 HTG Molecular Diagnostics
13.8.1 HTG Molecular Diagnostics Company Details
13.8.2 HTG Molecular Diagnostics Business Overview
13.8.3 HTG Molecular Diagnostics MicroRNA Introduction
13.8.4 HTG Molecular Diagnostics Revenue in MicroRNA Business (2015-2020)
13.8.5 HTG Molecular Diagnostics Recent Development
13.9 Meridian Life Science
13.9.1 Meridian Life Science Company Details
13.9.2 Meridian Life Science Business Overview
13.9.3 Meridian Life Science MicroRNA Introduction
13.9.4 Meridian Life Science Revenue in MicroRNA Business (2015-2020)
13.9.5 Meridian Life Science Recent Development
13.10 Rosetta Genomics
13.10.1 Rosetta Genomics Company Details
13.10.2 Rosetta Genomics Business Overview
13.10.3 Rosetta Genomics MicroRNA Introduction
13.10.4 Rosetta Genomics Revenue in MicroRNA Business (2015-2020)
13.10.5 Rosetta Genomics Recent Development
13.11 Dharmacon
10.11.1 Dharmacon Company Details
10.11.2 Dharmacon Business Overview
10.11.3 Dharmacon MicroRNA Introduction
10.11.4 Dharmacon Revenue in MicroRNA Business (2015-2020)
10.11.5 Dharmacon Recent Development
13.12 BioVendor
10.12.1 BioVendor Company Details
10.12.2 BioVendor Business Overview
10.12.3 BioVendor MicroRNA Introduction
10.12.4 BioVendor Revenue in MicroRNA Business (2015-2020)
10.12.5 BioVendor Recent Development
13.13 Miltenyi Biotec
10.13.1 Miltenyi Biotec Company Details
10.13.2 Miltenyi Biotec Business Overview
10.13.3 Miltenyi Biotec MicroRNA Introduction
10.13.4 Miltenyi Biotec Revenue in MicroRNA Business (2015-2020)
10.13.5 Miltenyi Biotec Recent Development
13.14 Kaneka Corporation
10.14.1 Kaneka Corporation Company Details
10.14.2 Kaneka Corporation Business Overview
10.14.3 Kaneka Corporation MicroRNA Introduction
10.14.4 Kaneka Corporation Revenue in MicroRNA Business (2015-2020)
10.14.5 Kaneka Corporation Recent Development
13.15 Abcam
10.15.1 Abcam Company Details
10.15.2 Abcam Business Overview
10.15.3 Abcam MicroRNA Introduction
10.15.4 Abcam Revenue in MicroRNA Business (2015-2020)
10.15.5 Abcam Recent Development
13.16 GeneCopoeia
10.16.1 GeneCopoeia Company Details
10.16.2 GeneCopoeia Business Overview
10.16.3 GeneCopoeia MicroRNA Introduction
10.16.4 GeneCopoeia Revenue in MicroRNA Business (2015-2020)
10.16.5 GeneCopoeia Recent Development
13.17 Promega Corporation
10.17.1 Promega Corporation Company Details
10.17.2 Promega Corporation Business Overview
10.17.3 Promega Corporation MicroRNA Introduction
10.17.4 Promega Corporation Revenue in MicroRNA Business (2015-2020)
10.17.5 Promega Corporation Recent Development
13.18 New England Biolabs
10.18.1 New England Biolabs Company Details
10.18.2 New England Biolabs Business Overview
10.18.3 New England Biolabs MicroRNA Introduction
10.18.4 New England Biolabs Revenue in MicroRNA Business (2015-2020)
10.18.5 New England Biolabs Recent Development
13.19 NanoString Technologies
10.19.1 NanoString Technologies Company Details
10.19.2 NanoString Technologies Business Overview
10.19.3 NanoString Technologies MicroRNA Introduction
10.19.4 NanoString Technologies Revenue in MicroRNA Business (2015-2020)
10.19.5 NanoString Technologies Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Illumina、Roche、Agilent、Bio-Rad、Sigma Aldrich、Qiagen、Thermo Fisher Scientific、HTG Molecular Diagnostics、Meridian Life Science、Rosetta Genomics、Dharmacon、BioVendor、Miltenyi Biotec、Kaneka Corporation、Abcam、GeneCopoeia、Promega Corporation、New England Biolabs、NanoString Technologies
【免責事項】
https://www.globalresearch.jp/disclaimer